Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-04-12FDA Approved: EDARBI — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for EDARBI (azilsartan medoxomil) submitted by Azurity Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2011-04-04Clinical Trial Update: I PREVENT - Irbesartan In Hypertensive Diabetic Patients [Phase 4]
Phase 4 clinical trial update for irbesartan in hypertensive patients with diabetes; the study (NCT00362258) has completed.
-
FDA approval · 2011-04-01FDA Approved: CARVEDILOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for carvedilol from Teva Pharmaceuticals USA, Inc., authorizing the marketing of the generic car…
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients [Phase 4]
Phase 4 trial update: Irbesartan in adults with mild to moderate hypertension has completed.
-
FDA approval · 2011-03-31FDA Approved: PRAZOSIN HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for prazosin hydrochloride (generic) under Mylan Pharmaceuticals Inc., expanding access to the gener…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-03-31Clinical Trial Update: The Chinese Mutation Hotspot of ENaC Causing Liddle's Syndrome and the Association of ENaC Variations and Hypertension
This clinical trial update discusses ENaC mutations linked to Liddle's syndrome and investigates associations between ENaC variations and hy…
-
FDA approval · 2011-03-30FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Losartan Potassium from Alembic Pharmaceuticals Limited, confirming approval of a generic produc…
-
FDA approval · 2011-03-30FDA Approved: FOSINOPRIL SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for fosinopril sodium from Aurobindo Pharma Limited, making it a generic product.
-
CLINICAL_TRIALS research · 2011-03-30Clinical Trial Update: Implementation of an Integrated Primary Care Network for Prevention and Management of Cardiometabolic Risks [NA]
An update on a trial to implement a network-based primary care approach for preventing and managing cardiometabolic risks, focusing on diabe…
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Hypertension in Hemodialysis [NA]
A completed clinical trial investigating hypertension in patients on hemodialysis, with a focus on left ventricular hypertrophy.
-
CLINICAL_TRIALS trial_result · 2011-03-25Clinical Trial Update: Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg [Phase 3]
Phase 3 trial comparing safety and efficacy of aliskiren (300 mg, 150 mg, and 75 mg) versus ramipril (5 mg) in essential hypertension, with …
-
FDA approval · 2011-03-25FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA notice related to a supplemental application for Tribenzor (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide) by Cosette…
-
CLINICAL_TRIALS trial_result · 2011-03-25Clinical Trial Update: A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly [Phase 3]
Phase 3 safety and efficacy trial comparing aliskiren (150 mg and 300 mg) with ramipril (5 mg and 10 mg) in elderly patients with hypertensi…
-
CLINICAL_TRIALS trial_result · 2011-03-25Clinical Trial Update: Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren [Phase 4]
This Phase 4 clinical trial evaluated the impact of high versus low sodium diets on blood pressure in hypertensive patients treated with ali…
-
CLINICAL_TRIALS trial_result · 2011-03-23Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of combining aliskiren with amlodipine in patients with hypertension not adequately contr…
-
FDA approval · 2011-03-22FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for Losartan Potassium submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2011-03-22FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (PD-Rx Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate (PD-Rx Pharmaceuticals, Inc.) under an ANDA. This action updates the approve…
-
FDA approval · 2011-03-17FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Inderal LA (propranolol hydrochloride) filed by ANI Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2011-03-17Clinical Trial Update: Using an Electronic Personal Health Record to Empower Patients With Hypertension [NA]
This completed clinical trial evaluates using an electronic personal health record to empower patients with hypertension.
-
CLINICAL_TRIALS research · 2011-03-17Clinical Trial Update: Role of AT1-receptor Blockers in Insulin-induced Vasodilation. [NA]
A clinical trial update from Maastricht University Medical Center examining whether AT1-receptor blockers influence insulin-induced vasodila…
-
FDA label_change · 2011-03-15FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for hydrochlorothiazide, resulting in changes to the product labeling.
-
FDA approval · 2011-03-11FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) from Almatica Pharma Inc.
-
FDA approval · 2011-03-11FDA Approved: VASERETIC — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for VASERETIC (enalapril maleate and hydrochlorothiazide) from Bausch Health US, LLC.
-
FDA approval · 2011-03-10FDA Approved: METOLAZONE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for metolazone by Sandoz Inc. It is a diuretic used to treat edema and hypertension.
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction [Phase 4]
A Phase 4 trial update assessed whether systolic blood pressure reduction with the combination of valsartan and amlodipine improves diastoli…